Shay Capital’s iTeos Therapeutics ITOS Stock Holding History

Shay Capital’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-210,516	Closed	-$2.1M	–	459
2025 Q2	$2.1M	Buy	+210,516	New	+$1.7M	0.24%	70

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Shay Capital's ITOS Position: Q3 2025 in Review

Shay Capital sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 210,516 shares — an estimated $2.1M sold.

Shay Capital first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $2.1M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Shay Capital reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Shay Capital sold 210,516 iTeos Therapeutics shares in Q3 2025, an estimated $2.1M.
Shay Capital first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Shay Capital's iTeos Therapeutics position peaked at $2.1M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Shay Capital's 13F filing for Q3 2025, filed 14 Nov 2025.